Rediff wins cybersquatting case against Pakistani individual

Daniyal Waseem was using domain name 'rediffpk.com'

PTI | June 28, 2010



Online services major Rediff.com India Ltd has won a cybersquatting dispute against a Pakistani person, who was using an identical domain name and illegally incorporating the Indian firm's trademark.

Daniyal Waseem of Quetta in Pakistan was using the domain name 'rediffpk.com'. To this, the Nasdaq-listed Indian firm had contended that the disputed Internet site was identical in part and confusingly similar as a whole to the 'Rediff' trademark, for which it has rights.

Cybersquatting is the practice of illegally buying and registering an address, which is the name of an existing company or a well-known brand or person, on the Internet.

To restrain the Pakistani person for using the trademark, the Mumbai-based Internet portal service provider had approached a Geneva-based World Intellectual Property Organisation on March 6 this year.

The WIPO Arbitration and Mediation Centre, a part of the United Nations, found that the respondent (Waseem) has no rights with regard to the domain name, and the registered site was being used in bad faith.

Syed Naqiz Shahabuddin, the sole panelist of the centre, ordered that the disputed domain be transferred to Rediff.

WIPO is the UN's specialised agency for developing a balanced and accessible international system in the field of intellectual property rights.

As per details available with the WIPO, the respondent acknowledged Rediff's rights to the trademark and was willing to be affiliated with it.

"...it was always the intent of the respondent to leverage off the complainant's goodwill by using the Rediff trademark, and it did not possess any rights or legitimate interests to the disputed domain name," Rediff had said in its argument.

This is not first time that Rediff.com has faced a cybersquatting dispute. According to Pravin Anand, lawyer with legal firm Anand and Anand, it has faced over 10 such cases at WIPO in the past. Anand and Anand represented Rediff.com at the WIPO.

The name 'Rediff.com' was adopted by the company in 1996.

It has registered the trademark REDIFF.COM and other REDIFF prefix marks such as REDIFF MAIL and REDIFF BOL on a worldwide basis, including the US and India.

Rediff.com India Ltd provides various online and e-commerce services, including email, news, shopping, chat, messenger and stock market updates.

 

Comments

 

Other News

Cabinet approves museum at North-South Block complex

The Cabinet Committee on Economic Affairs, chaired by prime minister Narendra Modi, on Wednesday has approved the development of the Yuge Yugeen Bharat Museum (YYBM) at the North and South Block Complex, New Delhi, at an estimated total project cost of ₹3,230 crore, as appraised by the Public Investmen

Cabinet approves extension of Noida metro corridor

The Union Cabinet, chaired by prime minister Narendra Modi, has approved the extension of Aqua Line Metro Rail Corridor from Noida Sector-51 to Greater Noida Sector-04 of Noida Metro Rail Project with corridor for a length of 8.449 km with 5 elevated stations. On operationalization of this corridor, Noid

India reaffirms commitment to climate multilateralism

India has reaffirmed its commitment to climate multilateralism and the principles of Equity and Common But Differentiated Responsibilities and Respective Capabilities (CBDR-RC), calling for a fair, equitable and ambitious outcome at the 31st Conference of the Parties (COP31) to the United Nations Framewo

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter